Literature DB >> 6307747

In vitro biosynthesis of the human cell surface receptor for transferrin.

C Schneider, U Asser, D R Sutherland, M F Greaves.   

Abstract

The human cell surface receptor for transferrin is a transmembrane phosphoglycoprotein composed of two disulphide linked and apparently identical subunits of Mr 90 000. Using an affinity purified, polyclonal rabbit antibody, we have studied the in vitro biosynthesis of this receptor. The primary translation product, synthesised in a rabbit reticulocyte lysate programmed with human placental RNA, appears to have the same Mr (78 000) as the unglycosylated molecule immunoprecipitated from tunicamycin-treated cells. In the presence of a dog pancreatic microsomal system the cell free system accurately reproduces the glycosylation and the asymmetric transmembrane integration.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6307747     DOI: 10.1016/0014-5793(83)80591-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Functional expression of the Fc-fused extracellular domains of group II membrane proteins.

Authors:  Weicheng Wu; Jing Jin; Xiaojuan Liu; Yufei Zhang; Meng Li; Miaomiao Shao; Yifan Qian; Dongmei Zhang; Haiyan Zhu; Yuanyuan Ruan; Jianhui Xie; Jianxin Gu
Journal:  Glycoconj J       Date:  2014-12-13       Impact factor: 2.916

2.  Binding of transferrin to the core protein of fibroblast proteoheparan sulfate.

Authors:  L A Fransson; I Carlstedt; L Cöster; A Malmström
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

3.  The transmembrane segment of the human transferrin receptor functions as a signal peptide.

Authors:  M Zerial; P Melancon; C Schneider; H Garoff
Journal:  EMBO J       Date:  1986-07       Impact factor: 11.598

4.  Isolation of cDNA clones for the human transferrin receptor.

Authors:  C Schneider; M Kurkinen; M Greaves
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.